ArticleWorld journal of radiology2026

Predictive model for vedolizumab efficacy in moderate-to-severe ulcerative colitis based on computed tomography-derived body compositions and nutritional inflammatory markers.

Xiao-Yan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.